학술논문
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
Document Type
Article
Author
Source
In Annals of Oncology October 2016 27(10):1928-1940
Subject
Language
ISSN
0923-7534